ROCKET PHARMACEUTICALS, INC.·4

Oct 29, 4:58 PM ET

Makker Gotham 4

4 · ROCKET PHARMACEUTICALS, INC. · Filed Oct 29, 2024

Insider Transaction Report

Form 4
Period: 2024-09-26
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-09-26+204204 total
    Exercise: $17.60Exp: 2034-09-26Common Stock (204 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-09-26+303303 total
    Exercise: $17.60Exp: 2034-09-26Common Stock (303 underlying)
Footnotes (2)
  • [F1]This option represents a right to purchase a total of 204 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on September 26, 2025.
  • [F2]This option represents a right to purchase a total of 303 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on September 26, 2025.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4